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INTRODUCTION:
AIMS:
-Review the mechanisms in which resistances are being
produced in P.aeruginosa and E.coli.
-Localize the sites where mutations are given.
METHODOLOGY:
ESCHERICHIA COLI
EFFLUX PUMPS: AcrA-AcrB-TolC and YhiU-YhiV-TolC belonging to RND
superfamily, and MdfA-Cmr pump belonging to MFS superfamily.
1. AcrA-AcrB-TolC is related with a resistance when there is a
overexpression of sdiA (involved in regulation cell division) and marA
(activator modulating of acrA, acrB and tolC.). The early resistant stage of
FQs is caused by efflux pumps, and the high level stage is mediated by
QRDRs of gyrA, gyrB, parC and parE.
2. Porins are involved in resistance: a decreased expression in OmpF
protein (porin complex in the outer membrane) that takes part in the
pump, increases MIC of FQ, it is regulated by MarA, affecting at AcrA-AcrB
gene expression.
Moreover, if the expression of OmpX is increased contributes to resistance 
also, because OmpX downregulates OmpF porin. 
EFFLUX PUMPS involved:MexAB-OprM,MexXY-OprM,MexCD-OprJ
and MexEF-OprN.
Moreover the regulator genes involving the main pumps are : mexT,
mexS and mvaT, when they are inactivated, overexpress MexEF-
OprN operon, which is the main pump that causes FQs resistance. It
has been reported that MexEF-OprN pump alleviates oxidative
stress induced by the drugs. Also, SOS response triggered by FQs
increases the number of mutations in QRDRs and so the resistance
levels.
QRDRs in DNA gyrase and Topoisomerase IV: GyrA and ParC subunits are
involved in resistance. The mutations are located to the amino terminus
that has the active site (formed by a tyrosine covalently linked to the
broken DNA strand during enzyme action).
It’s known that low level resistances of FQs are due to a single mutation in
gyrA. However, a second step mutation in gyrA and additional mutations in
parC or parE can develop in a high-level resistance.
The 2nd generation of FQs the mutations develop even faster than in the
third.
The presence of SNPs within QRDRs of gyrA, gyrB, parC, and parE is
related with phenotypic resistance to FQ in P. aeruginosa. The
majority of mutations occurred in amino acid positions 466 to 468.
In figure S2: Bruchann, Dösch et al, characterised the antibiotic
resistance profiles from cystic fibrosis strains pyrosequencing,
sequencing with sanger and making a PCR from all QRDRs. It was
reported that mutations in QRDR of gyrA or gyrB increased MIC of
ciprofloxacin 8-to 16-fold.
Fluoroquinolones (FQs) are made with an
addition of a fluorine molecule to quinolones,
their main function was treating urinary
diseases, respiratory infections or gonorrhea.
There are 4 generations of FQs. Mechanism of
action: FQs inhibit microbial DNA synthesis,
interacting with DNA gyrase (Topoisomerase II)
which allows the relaxation of chromatin
affecting the negative supercoiling, essential for
the access of the main enzymes for replication,
so that when it is blocked the replication does
not take place. They inhibit also topoisomerase
IV, which separates the replicated
chromosomes during the cell cycle. They form a
physical barrier to the movement of the
replication fork, affecting the maintenance of
supercoiling.
Light, medium, and
dark shaded circles
represent sensitive
intermediate, and
resistant isolates.
Figure S1: Main FQs resistance
mechanisms of bacteria
OTHER MECHANISMS: -A putative deacetylase (dnpA) is involved in
persistence, related with non-dividing cells,when overexpressed in wt
cells increases the number of persister cells, resistant to antibiotics.
ppGpp (alarmone) high levels,released in harsh environments in
bacteria, in higher levels restores the FQ sensibility, because
produces less persister cells SOS response.
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CONCLUSIONS:
FUTURE 
PERSPECTIVES: 
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